194 related articles for article (PubMed ID: 36012307)
1. A
Rocha JD; Uribe D; Delgado J; Niechi I; Alarcón S; Erices JI; Melo R; Fernández-Gajardo R; Salazar-Onfray F; San Martín R; Quezada Monrás C
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012307
[TBL] [Abstract][Full Text] [Related]
2. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
Liu TZ; Wang X; Bai YF; Liao HZ; Qiu SC; Yang YQ; Yan XH; Chen J; Guo HB; Zhang SZ
Int J Biochem Cell Biol; 2014 Apr; 49():8-16. PubMed ID: 24434023
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells.
Torres A; Vargas Y; Uribe D; Jaramillo C; Gleisner A; Salazar-Onfray F; López MN; Melo R; Oyarzún C; San Martín R; Quezada C
Oncotarget; 2016 Oct; 7(41):67373-67386. PubMed ID: 27634913
[TBL] [Abstract][Full Text] [Related]
4. FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells.
Torres Á; Arriagada V; Erices JI; Toro MLÁ; Rocha JD; Niechi I; Carrasco C; Oyarzún C; Quezada C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208561
[TBL] [Abstract][Full Text] [Related]
5. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A
Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C
Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling.
Uribe D; Torres Á; Rocha JD; Niechi I; Oyarzún C; Sobrevia L; San Martín R; Quezada C
Mol Aspects Med; 2017 Jun; 55():140-151. PubMed ID: 28223127
[TBL] [Abstract][Full Text] [Related]
7. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A
Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS
J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness.
Niechi I; Uribe-Ojeda A; Erices JI; Torres Á; Uribe D; Rocha JD; Silva P; Richter HG; San Martín R; Quezada C
Cells; 2019 Oct; 8(11):. PubMed ID: 31671624
[TBL] [Abstract][Full Text] [Related]
9. Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.
Alarcón S; Toro MLÁ; Villarreal C; Melo R; Fernández R; Ayuso Sacido A; Uribe D; San Martín R; Quezada C
Cells; 2020 Aug; 9(8):. PubMed ID: 32824670
[TBL] [Abstract][Full Text] [Related]
10. The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia.
Rocha R; Torres Á; Ojeda K; Uribe D; Rocha D; Erices J; Niechi I; Ehrenfeld P; San Martín R; Quezada C
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670017
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
12. The Impact of A3AR Antagonism on the Differential Expression of Chemoresistance-Related Genes in Glioblastoma Stem-like Cells.
Peñate L; Carrillo-Beltrán D; Spichiger C; Cuevas-Zhbankova A; Torres-Arévalo Á; Silva P; Richter HG; Ayuso-Sacido Á; San Martín R; Quezada-Monrás C
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794149
[TBL] [Abstract][Full Text] [Related]
13. The low affinity A2B adenosine receptor enhances migratory and invasive capacity
Erices JI; Niechi I; Uribe-Ojeda A; Toro MLÁ; García-Romero N; Carrión-Navarro J; Monago-Sánchez Á; Ayuso-Sacido Á; Martin RS; Quezada-Monrás C
Front Oncol; 2022; 12():969993. PubMed ID: 36059665
[TBL] [Abstract][Full Text] [Related]
14. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
[TBL] [Abstract][Full Text] [Related]
15. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
Sgubin D; Wakimoto H; Kanai R; Rabkin SD; Martuza RL
Stem Cells Transl Med; 2012 Apr; 1(4):322-32. PubMed ID: 23197811
[TBL] [Abstract][Full Text] [Related]
17. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
18. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
20. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.
Kolenda J; Jensen SS; Aaberg-Jessen C; Christensen K; Andersen C; Brünner N; Kristensen BW
J Neurooncol; 2011 May; 103(1):43-58. PubMed ID: 20835751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
